article thumbnail

J&J, AbbVie, Sanofi and many other companies face competition probe in Turkey

Fierce Pharma

Turkish authorities have launched an investigation into 19 pharmaceutical companies to probe whether their operations violated the country’s competition law, the Turkish Competition Authority discl | The companies, which include Pfizer, J&J, Sanofi, AbbVie, AstraZeneca, Merck and others are being probed for potentially violating Turkish competition (..)

article thumbnail

The New Radiopharma Competition Requires Unprecedented Medical Logistics

MedCity News

As the innovative, multi-billion dollar industry expands rapidly, pharma companies must consider how to deliver and differentiate. The post The New Radiopharma Competition Requires Unprecedented Medical Logistics appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Making Strategic Sense of Pharma’s New Race for Competitive Advantage

Fierce Pharma

The race for competitive advantage for pharma today is about far more than just innovative new molecules.

article thumbnail

Rethinking PPC: Strategies for Pharma Marketers in a Competitive Landscape

Pharma Marketing Network

Pharmaceutical marketers are facing a more competitive landscape than ever before, with a variety of new technologies and strategies to keep up with. As such, it is essential to rethink and refine PPC strategies to stay competitive. Understanding the Pharma PPC Landscape The pharma PPC landscape is complex and ever-evolving.

article thumbnail

ESMO: In showdown with Merck's Keytruda, BMS' Opdivo delivers competitive perioperative lung cancer data

Fierce Pharma

In the race for leadership in the treatment of early-stage non-small cell lung cancer (NSCLC), Bristol Myers Squibb has put up trial data that look competitive to those from Merck’s Keytruda. | But a key debate remains unsettled.

article thumbnail

Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret

Fierce Pharma

Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret kdunleavy Fri, 03/10/2023 - 10:22

article thumbnail

Biosimilar Insulins Promise Patients New Choices, But Competition Is Still Lacking

MedCity News

The big three insulin manufacturers have cut prices across their product lineups, but potential competition from other biosimilar insulins is still in earlier stages of development. Insulin prices have long been a pain point for diabetics.